Skip to content
Governance Register

← US public companies

Hemispherx Biopharma INC

SEC CIK 946644 · heb · last insider filing 2026-03-16

Directors (from insider filings)

NameCapacity as filedFilings
Chemerow David I. Director filed 2025 - 2026
Equels Thomas K. Director · Vice Chairman of Board filed 2008 - 2026
Kellner TED D Director filed 2024 - 2025
Mitchell William M Director filed 2007 - 2025
Rodino Peter W. III Director · Exec Dir Govt Relations/Sectry filed 2013 - 2025
Bryan Nancy Director filed 2023 - 2025
Appelrouth Stewart Director filed 2017 - 2025
Kiani Iraj Eqhbal Director filed 2007 - 2016
Carter William A Director · Chief Executive Officer filed 2006 - 2015
Piani Richard Director filed 2006 - 2012
Etheridge Ransom Director · Secretary and General Counsel filed 2007 - 2008
Spence Steven D Director filed 2006 - 2007

Officers (from insider filings)

NameTitle as filedFilings
Lintal Ellen M Chief Financial Officer filed 2019 - 2023
Dickey Robert IV Senior Vice President filed 2009 - 2022
Strayer David R Medical Director filed 2007 - 2019
Springate Wayne S. Vice President of Operations filed 2009 - 2019
Pascale Adam Chief Accounting Officer filed 2014 - 2019
Cavalli Ralph Christopher VP, Quality Control filed 2011 - 2012
Bernhardt Charles Thomas III Chief Financial Officer filed 2009 - 2011
Lander Russel J VP of Process/QualityAssurance filed 2011 - 2011
Peterson Robert E Chief Financial Officer filed 2007 - 2008
Bonelli Anthony President, COO filed 2006 - 2007

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.